Tekla Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$17.9M Buy
189,597
+18,451
+11% +$1.74M 0.7% 41
2023
Q1
$14.2M Sell
171,146
-242
-0.1% -$20K 0.54% 41
2022
Q4
$12.8M Hold
171,388
0.48% 49
2022
Q3
$14.2M Hold
171,388
0.58% 43
2022
Q2
$16.3M Sell
171,388
-5,800
-3% -$552K 0.64% 41
2022
Q1
$20.9M Hold
177,188
0.73% 37
2021
Q4
$23M Sell
177,188
-17,442
-9% -$2.26M 0.74% 38
2021
Q3
$22M Sell
194,630
-26,925
-12% -$3.05M 0.71% 41
2021
Q2
$22.9M Sell
221,555
-17,200
-7% -$1.78M 0.75% 35
2021
Q1
$20M Sell
238,755
-26,200
-10% -$2.19M 0.69% 39
2020
Q4
$24.2M Sell
264,955
-26,200
-9% -$2.39M 0.85% 35
2020
Q3
$23.2M Buy
291,155
+89,009
+44% +$7.1M 0.87% 30
2020
Q2
$14M Hold
202,146
0.53% 42
2020
Q1
$12.7M Sell
202,146
-6,525
-3% -$410K 0.57% 39
2019
Q4
$16.2M Buy
208,671
+12,951
+7% +$1.01M 0.61% 38
2019
Q3
$14.3M Sell
195,720
-13,587
-6% -$996K 0.63% 40
2019
Q2
$12.9M Buy
209,307
+38,913
+23% +$2.4M 0.53% 44
2019
Q1
$10.9M Hold
170,394
0.44% 51
2018
Q4
$8.7M Sell
170,394
-59,694
-26% -$3.05M 0.37% 57
2018
Q3
$13.4M Buy
230,088
+31,263
+16% +$1.81M 0.48% 49
2018
Q2
$9.65M Hold
198,825
0.37% 63
2018
Q1
$9.25M Buy
198,825
+3,525
+2% +$164K 0.36% 61
2017
Q4
$7.34M Sell
195,300
-96,900
-33% -$3.64M 0.28% 69
2017
Q3
$10.6M Buy
+292,200
New +$10.6M 0.38% 51
2017
Q2
Sell
-167,700
Closed -$5.26M 145
2017
Q1
$5.26M Buy
+167,700
New +$5.26M 0.2% 86